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Abstract: Urinary tract infections (UTIs) are common bacterial infections caused mainly by enteric
bacteria. Numerous virulence factors assist bacteria in the colonization of the bladder. Bacterial
efflux pumps also contribute to bacterial communication and to biofilm formation. In this study, the
phenotypic and genetic antibiotic resistance of clinical UTI pathogens such as Escherichia coli, Klebsiella
pneumoniae, and Proteus mirabilis were determined by disk diffusion method and polymerase chain
reaction (PCR). Following this, different classes of antibiotics were evaluated for their antibacterial
activity at pH 5, 6, 7 and 8 by a microdilution method. Gentamicin (GEN) was the most potent
antibacterial agent against E. coli strains. The effect of GEN on the relative expression of marR and
sdiA genes was evaluated by quantitative PCR. The slightly acidic pH (pH 6) and GEN treatment
induced the upregulation of marR antibiotic resistance and sdiA QS activator genes in both E. coli
strains. Consequently, bacteria had become more susceptible to GEN. It can be concluded that
antibiotic activity is pH dependent and so the artificial manipulation of urinary pH can contribute to
a more effective therapy of multidrug resistant bacterial infections.
Keywords: urinary tract infection (UTI); multidrug resistance; quorum sensing; efflux pump; biofilm;
pH dependence
1. Introduction
Urinary tract infections (UTIs) are one of the most frequently encountered bacterial
infections in everyday health care. There are various classifications of UTIs: lower (lim-
ited to the bladder) or upper (pyelonephritis), complicated (in patients with a catheter,
structural or functional abnormality or pregnant), or uncomplicated (none of the above).
The diagnosis depends on the urinary symptoms and on the urine culture positive for
an uropathogen exceeding a given threshold (which varies according to gender and the
presence of a urinary catheter). Both patient and bacterial factors contribute to the develop-
ment of UTIs. Anatomical or functional abnormalities, genetic predisposition, and certain
behaviors (e.g., sexual intercourse) can increase susceptibility to uropathogens [1]. Several
virulence factors aid the bacteria in the colonization of the bladder and the evasion of the
immune system. These include the urease enzyme, adhesins, biofilm formation, toxins,
and iron acquisition systems [2].
The dominant bacterial species involved in uncomplicated and complicated UTIs is
uropathogenic Escherichia coli (UPEC). Other species include Klebsiella pneumoniae, Staphy-
lococcus saprophyticus, Enterococcus faecalis, group B Streptococcus (GBS), Proteus mirabilis,
Pseudomonas aeruginosa, Staphylococcus aureus, and Candida spp. [3]. Commonly used antibi-
otics for treating UTIs are trimethoprim sulfamethoxazole, third generation cephalosporins,
ciprofloxacin, and ampicillin. However, as a result of emerging multidrug resistance,
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antibiotic treatment is becoming more difficult. This is more pronounced in the case of
the Enterobacteriaceae family, which has resistance to third-generation cephalosporines
and other antibiotics [4] through its production of extended spectrum β-lactamases (ESBL),
class C β-lactamases (AmpC enzymes) and carbapenemases.
Emerging multidrug resistance and the high recurrence rate of UTIs pose a signifi-
cant threat, particularly to women, infant boys, and older men. The use of prophylactic
antibiotics is no longer sustainable. However, vaccine therapies and anti-virulence factor
therapies could be promising strategies [5]. Another attractive approach to battle multidrug
resistance is single-dose aminoglycoside therapy, saving carbapenems for treatment of
severe infections. Aminoglycosides are excreted in high concentrations in urine and, with
a single parenteral dose, patient non-adherence can be avoided [6,7].
Urinary pH levels vary broadly (pH 4.5–8) and can be easily modified by diet or
medications. Modification of the urinary pH could play an important role both in the
treatment and in the prevention of UTIs, since pH is an essential factor in the colonization
and proliferation of uropathogenic bacteria and modifies the efficacy of antibiotics [8–10].
Siderocalin (SCN), a lipocain-type molecule produced also by uroepithelial cells, has a
key function in the host defense system. It binds iron-binding siderophores (for example,
enterobactin) released by microorganisms, however SCN activity levels can be influenced
by pH and metabolites [11].
Quorum sensing (QS) is a cell–cell communication system which regulates gene
expression based on population density. It enables bacteria to form biofilms and express
various virulence factors, which can contribute to increased drug resistance [12]. QS is also
involved in the pathogenesis of UTIs, especially catheter-associated urinary tract infections
(CAUTIs). It regulates motility and biofilm formation, allowing the colonization of the
bladder [13]. Urine composition is a crucial host factor that can alter the risk of a UTI; a
pH less than 5, organic acids, and high urea content make the environment less ideal for
bacterial growth. Moreover, urea in the urine is also able to inhibit the expression of QS
related genes [14]. Efflux pumps (EPs) are membrane proteins that are mostly associated
with antibiotic resistance, however they may also have a major role in the formation of
biofilm and in QS regulation. EPs may take part in the efflux of antibiotics and metabolic
intermediates, along with extracellular polymeric substances and QS molecules. They
can influence aggregation and indirectly regulate biofilm-associated genes. Therefore, the
development of molecules with efflux pump inhibitory activity may appeal in order to
reverse multidrug resistance in bacteria and also as anti-biofilm agents [15].
2. Results
2.1. Antibiotic Susceptibility Test
In vitro antibiotic susceptibility tests were conducted on six UTI bacterial isolates
and MIC breakpoints were determined according to EUCAST guidelines [16]. Fifteen
antibacterial agents were used for the susceptibility testing (cefuroxime, ceftriaxone, cef-
tazidime, ceftazidime/avibactam, trimethoprim/sulfamethoxazole, ertapenem, imipenem,
meropenem, gentamicin, tobramycin, amikacin, ciprofloxacin, norfloxacin, ampicillin, and
amoxicillin-clavulanic acid).
E. coli 32313 was susceptible to all antibiotics but resistant to trimethoprim/sulfametho
xazole, gentamicin, ciprofloxacin, and norfloxacin. E. coli 33504 was completely susceptible
to all antibiotics. K. pneumoniae 33443 was resistant to ampicillin, ciprofloxacin, and nor-
floxacin. K. pneumoniae 33163 was susceptible to ceftazidime/avibactam and intermediate
for tobramycin and amikacin but was resistant to the other antibiotics. P. mirabilis 33877
was resistant to ampicillin and trimethoprim/sulfamethoxazole but was susceptible to all
other tested antibiotics. P. mirabilis 32470 was susceptible to ceftazidime/avibactam and
intermediate to amikacin but was resistant to the other antibiotics tested. All strains were
susceptible to ertapenem, meropenem, and imipenem.
The results of phenotypic and genetic investigations are presented in Tables 1 and 2,
respectively.
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Table 1. Phenotypic antibacterial susceptibility results.







Ampicillin 22 mm S 25 mm S 6 mm R 0 mm R 0 mm R 0 mm R
AMC 22 mm S 25 mm S 23 mm S 8 mm R 28 mm S 0 mm R
Cefuroxime 22 mm S 25 mm S 20 mm S 0 mm R 28 mm S 0 mm R
Ceftriaxone 30 mm S 34 mm S 24 mm S 8 mm R 30 mm S 15 mm R
Ceftazidime 27 mm S 30 mm S 24 mm S 8 mm R 30 mm S 8 mm R
CZA 26 mm S 28 mm S 24 mm S 24 mm S 30 mm S 28 mm S
TMP/SMX 0 mm R 30 mm S 18 mm S 0 mm R 0 mm R 0 mm R
Ertapenem 35 mm S 35 mm S 30 mm S 30 mm S 30 mm S 30 mm S
Imipenem 30 mm S 30 mm S 30 mm S 30 mm S 30 mm S 30 mm S
Meropenem 30 mm S 30 mm S 30 mm S 30 mm S 30 mm S 30 mm S
Gentamicin 13 mm R 22 mm S 20 mm S 0 mm R 24 mm S 15 mm R
Tobramycin 20 mm S 22 mm S 20 mm S 15 mm I 24 mm S 14 mm R
Amikacin 20 mm S 22 mm S 20 mm S 25 mm I 24 mm S 22 mm I
Ciprofloxacin 0 mm R 30 mm S 16 mm R 0 mm R 35 mm S 0 mm R
Norfloxacin 0 mm R 30 mm S 16 mm R 0 mm R 35 mm S 0 mm R
AMC: amoxicillin-clavulanic acid, TMP/SMX: Trimethoprim Sulfamethoxazole (sumetrolim), CZA: Ceftazidime/Avibactam.
Table 2. ESBL, quinolone, and sulfonamide resistance genes in UTI bacterial isolates.
Resistance Type Gene
Escherichia coli Proteus mirabilis Klebsiella pneumoniae
32313 33504 32470 33877 33163 33443
ESBL
tem − − + − + +
shv − − + + − −
oxa − − + − − −
ctx-m − − + − − −
Fluoroquinolones
qnrA − − − − − −
qnrD − − − − − −
qnrB − − − − − −
qnrS − − − − − −
oqxAB − − + + + +
aac(69)-Ib-cr + − + − + −
qepA − − − − − −
qnrC − − − − − −
Resistance type
sul1 − − − − − −
sul2 + − + + + +
sul3 − − − + − −
2.2. Genetic Investigation
By PCR 3 tem, 2 shv, 1 ctx-m and 1 oxa amplicons were found for ESBL screening.
Furthermore, 4 oqxAB and 3 aac(69)-Ib-cr and quinolone resistance genes were detected. In
addition, 4 sul2 and 1 sul3 sulfonamide resistance genes were identified. The results of the
genetic investigations are presented in Table 2.
2.3. Antibacterial Activity
After the determination of resistance genes, different classes of antibiotics, namely
erythromycin (ERY), ampicillin (AMP), ciprofloxacin (CIP), and gentamicin (GEN), were
evaluated for their antibacterial activity. Since urinary pH could have an impact on the
treatment of UTIs, the activity of antibiotics at different pH values is a critical issue. This
antibiotic evaluation was performed at pH 5, 6, 7 and 8 by microdilution method on
clinical strains of E. coli, P. mirabilis, and K. pneumoniae. The results show that ERY had
no antibacterial effect at pH 5 and 6. At pH 7 and 8, significant activity was observed on
sensitive E. coli 33504 and K. pneumoniae 33443 strains. ERY prevented the growth of tested
bacteria most effectively in alkaline environment (pH 8; Table 3).
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Table 3. Minimal inhibitory concentrations for erythromycin, ampicillin, ciprofloxacin and gentamicin on E. coli, K.
pneumoniae and P. mirabilis strains.
MIC (µg/mL)
Erythromycin Ampicillin Ciprofloxacin Gentamicin
pH pH pH pH
5 6 7 8 5 6 7 8 5 6 7 8 5 6 7 8
E. coli 33504 >100 >100 12.5 3.125 12.5 12.5 12.5 25 3.125 0.39 0.05 <0.05 25 6.25 1.56 0.05
E. coli 32313 >100 >100 >100 >100 >25 >25 >25 >25 >25 >25 25 >25 25 12.5 1.56 1.56
K. pneumoniae 33443 >100 >100 25 12.5 >25 >25 >25 >25 25 6.25 0.78 0.19 25 6.25 0.78 <0.05
K. pneumoniae 33163 >100 >100 >100 25 >25 >25 >25 >25 >25 >25 >25 12.5 >25 >25 >25 12.5
P. mirabilis 33877 >100 >100 >100 50 >25 >25 >25 >25 0.78 <0.05 <0.05 <0.05 >25 >25 6.25 0.39
P. mirabilis 32470 >100 >100 100 25 >25 >25 >25 >25 >25 >25 >25 >25 >25 >25 12.5 3.125
AMP had no effect on the tested strains (MIC greater than 100 µg/mL) except E. coli
33504. Here, AMP showed potent antibacterial activity at pH 5–7 (MIC: 12.5 µg/mL;
Table 3). pH dependence was also detected for CIP on E. coli 33504, K. pneumoniae 33443,
K. pneumoniae 33163, and P. mirabilis 33877 by showing higher antibacterial activity at pH 7
and 8 (Table 3). GEN was the most active antibiotic at alkaline pH of all tested strains
(Table 3).
2.4. Relative Expression of marR and sdiA Genes
GEN was the most potent antibacterial agent against E. coli strains (33504 and 32313)
and, for this reason, the effect of GEN on the relative expression of marR and sdiA genes
in both E. coli strains was evaluated. The E. coli marR gene encodes a repressor of the
marRAB operon, a regulatory locus controlling multiple antibiotic resistance. In addition,
sdiA encodes the transcription factor SdiA, a LuxR homolog that can respond to acyl-
homoserine lactone (AHL), which, in turn, is related to quorum sensing. As shown by
Figures 1 and 2, GEN treatment in a pH 6 environment induced a significant stress response
in both E. coli strains with the marR and sdiA genes being upregulated compared to the
other pH levels. In contrast, marR and sdiA genes at pH 8 and in the presence of GEN were




Antibiotics 2021, 10, x. https://doi.org/10.3390/xxxxx www.mdpi.com/journal/antibiotics 
AMP had no effect on the tested strains (MIC greater than 100 μg/mL) except E. coli 
33504. Here, AMP showed potent antibacterial activity at pH 5–7 (MIC: 12.5 μg/mL; Table 
3). pH dependence was also detected for CIP on E. coli 33504, K. pneumoniae 33443, K. 
pneumoniae 33163, and P. mirabilis 33877 by showing higher antibacterial activity at pH 7 
and 8 (Table 3). GEN was the most active antibiotic at alkaline pH of all tested strains 
(Table 3). 
2.4. Relative Expression of marR and sdiA Genes 
GEN was the most potent antibacterial agent against E. coli strains (33504 and 32313) 
and, for this reason, the effect of GEN on the relative expression of marR and sdiA genes 
in both E. coli str ins was evaluated. The E. coli marR g ne encodes a repressor of the mar-
RAB operon, a regulatory locus controlling multiple antibiotic resistance. In addition, sdiA
encodes the transcription factor SdiA, a LuxR homolog that can respond to acyl-homoser-
ine lactone (AHL), which, in turn, is related to quorum sensing. As shown by Figures 1 
and 2, GEN treatment in a pH 6 environment induced a significant stress response in both 
E. coli strains with the marR and sdiA genes being upregulated compared to the other pH 
levels. In contrast, marR and sdiA genes at pH 8 and in the presence of GEN were down-




































Figure 1. Relative gene expression levels of marR and sdiA genes in the presence of gentamicin in 
Escherichia coli 32313 after 8 h exposure. The line denotes the threshold value, which was set at a 
two-fold increase in transcripts. 
Figure 1. Relative gene expression levels of marR and sdiA genes in the presence of gentamicin in
Escherichia coli 32313 after 8 h exposure. The line denotes the threshold value, which was set at a
two-fold increase in transcripts.
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Figure 2. Relative gene expression levels of marR and sdiA genes in the presence of gentamicin in 
Escherichia coli 33504 after 8 h exposure. The line denotes the threshold value, which was set at a 
two-fold increase in transcripts. 
3. Discussion 
The results demonstrate that the genetic data agrees mostly with the phenotypical 
investigations, although there are some differences between the two methods. In E. coli 
32313 clinical strain, having taken into consideration that the aac(69)-Ib-cr gene is also re-
sponsible for concurrent aminoglycoside and fluoroquinolone resistance induction [17], 
the genetic background of fluoroquinolone and the sulfonamide resistance agrees with 
the phenotype. P. mirabilis 33877 strain has one fluoroquinolone resistance gene present 
(oqxAB), which does not correspond to the phenotypic investigation. Finally, K. pneu-
moniae 33443 contained the sul2 gene, which was phenotypically inactive. 
There are two possible reasons for these differences. The first possible reason is that 
the genetic investigation was not quantitative and there were insufficient copies of the 
gene. The genetic investigation could be quantified using more sensitive quantitative real-
time PCR. Additionally, oqxAB confers low to intermediate resistance to quinolones [16]. 
According to the literature, there is no complete agreement between phenotypical and 
genetic methods, therefore these differences could have been caused by multiple factors, 
for example, by the lack of promoter regions (an IS26 element in the case of oqxAB) [18,19]. 
It was demonstrated that the acidic pH and promethazine treatment induced a significant 
stress response in E. coli. Moreover, the genes marB, marR, acrA, acrB, soxS, ftsI and sdiA 
were up-regulated at an acidic pH compared to the treatment at a neutral pH [20]. 
In this study, the activity of the antibiotics of different classes was studied by broth 
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It can be concluded that the activity of ERY, CIP, and GEN was more effective in an alka-
line environment on the tested strains. Furthermore, AMP showed a more potent efficacy 
at acidic and neutral pH levels on E. coli 33504. Urine pH can be modified to prevent cer-
tain urological diseases [10]. Patient urinary pH can be acidified by ascorbic acid and am-
monium chloride while becoming more alkaline with sodium bicarbonate or potassium 
citrate [10]. The results confirmed that the activity of antimicrobial drugs is pH dependent. 
This enables the artificial manipulation of urinary pH to contribute to a more effective 
therapy of urinary tract infections, especially in cases of infections caused by multidrug 
resistant bacteria. Additionally, this technique could reduce the cost of treatment. 
The slightly acidic pH (pH 6) and GEN treatment induced the upregulation of marR 
antibiotic resistance and sdiA QS activator genes in both E. coli strains, increasing bacterial 
Figure 2. Relative gene expression levels of marR and sdiA genes in the presence of gentamicin in
Escherichia coli 33504 after 8 h exposure. The line denotes the threshold value, which was set at a
two-fold increase in transcripts.
3. Discussion
The results demonstrate that the genetic data agrees mostly with the phenotypical
investigations, alth ugh here are some differences b tween the two m thods. In E. coli
32313 clinical strain, having taken into consid ration that the aac(69)-Ib-cr ge e is also
respons ble for concurrent mi oglycoside and fluoroquinolone resistanc induction [17],
the genetic backg ound of fluoroquinolone and the sulf amide resista ce agrees with
the phenotype. P. mirabilis 33877 strain has one fluoroquinolone resistance en present
(oqxAB), which does not correspond to the ph notypic investigation. Fi ally, K. pneumoniae
33443 contained the sul2 gene, which was phenotypically inactive.
There are wo possible reasons for t ese differences. The first possible reason is that
the g n tic investigation w not quantitative and there we e insuffici nt copie of the
gene. The genetic investigation co ld be quantified using more sensitive quantitative r al-
time PCR. Additionally, oqxAB confers low to intermediate resistance to quinolones [16].
According to the literature, there is no complete agreement between phenotypical and
genetic methods, therefore these differences could have been caused by multiple factors,
for example, by the lack of promoter regions (an IS26 element in the case of oqxAB) [18,19].
It was demonstrated that the acidic pH and promethazine treatment induced a significant
stress response in E. coli. Moreover, the genes marB, marR, acrA, acrB, soxS, ftsI and sdiA
were up-regulated at an acidic pH compared to the treatment at a neutral pH [20].
In this study, the activity of the antibiotics of different classes was studied by broth
microdilution method at pH 5, 6, 7 and 8 on sensitive and resistant UTI bacterial strains. It
can be concluded that the activity of ERY, CIP, and GEN was more effective in an alkaline
environment on the tested strains. Furthermore, AMP showed a more potent efficacy
at acidic and neutral pH levels on E. coli 33504. Urine pH can be modified to prevent
certain urological diseases [10]. Patient urinary pH can be acidified by ascorbic acid and
ammonium chloride while becoming more alkaline with sodium bicarbonate or potassium
citrate [10]. The results confirmed that the activity of antimicrobial drugs is pH dependent.
This enables the artificial manipulation of urinary pH to contribute to a more effective
therapy of urinary tract infections, especially in cases of infections caused by multidrug
resistant bacteria. Additionally, this technique could reduce the cost of treatment.
The slightly acidic pH (pH 6) and GEN treatment induced the upregulation of marR
antibiotic resistance and sdiA QS activator genes in both E. coli strains, increasing bacterial
susceptibility. A possible explanation for this could be the pH-dependent activity of
siderocalin (SCN) protein, which is produced by uroepithelium. This has the ability to
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bind the iron-binding enterobactin. In a previous study, the activity of SCN increased
at pH > 6.45. The elevated pH facilitated host-derived ferric-aryl complex assembly in
SCN, leading to the iron starvation of uropathogenic E. coli (UPEC) [11]. This observation
suggests that E. coli at pH 6 is more susceptible to the antimicrobial agents that caused
the over-expression of marR and sdiA genes. It needs to be highlighted that our study
represents in vitro results lacking the response of the host to UPEC, therefore host factors
should also be included in further in vivo studies.
4. Materials and Methods
4.1. Bacterial Strains
Clinical strains of Escherichia coli 33503, 32313; Klebsiella pneumoniae 33443, 33163;
Proteus mirabilis 3387, 32470 were provided by the Institute of Clinical Microbiology at the
University of Szeged and were included for the investigations. The species identities of the
clinical isolates were confirmed by both MALDI-TOF MS and conventional biochemical
methods.
4.2. Determination of Minimum Inhibitory Concentrations by Microdilution Method
The minimum inhibitory concentrations (MICs) of antibiotics (erythromycin (ERY),
ampicillin (AMP), ciprofloxacin (CIP), and gentamicin (GEN)) were determined by mi-
crodilution method in 96-well plates according to the Clinical and Laboratory Standards
Institute (CLSI) guidelines using MHB at pH 5, 6, 7 and 8 [21]. The bacterial strains were
separately cultured in media of pH 5 to pH 8 overnight at 37 ◦C and the bacterial culture
grown at the appropriate pH was applied in the assay.
4.3. Disk Diffusion
The antibiotic susceptibilities of clinical isolates were determined by Kirby–Bauer’s
disk diffusion method. Susceptibility and resistance were determined according to the
Clinical and Laboratory Standards Institute criteria [21].
Briefly, a suspension of the bacteria equal to a 0.5 McFarland standard was prepared
in phosphate-buffered saline (PBS, pH 7.2) from an overnight culture. Using a swab, strains
were inoculated onto a Mueller–Hinton agar (MHA; Bio-Rad, Hercules, CA, USA) plate.
Tested antimicrobials were ampicillin (10 µg), amoxicillin-clavulanic acid (20/10 µg),
cefuroxime (30 µg), ceftriaxone (30 µg), ceftazidime (10 µg), ceftazidime/avibactam (30/20 µg),
trimethoprim sulfamethoxazole (1.25/23.75 µg), ertapenem (10µg), imipenem (10 µg),
meropenem (10 µg), gentamicin (10 µg), tobramycin (10 µg), amikacin (30 µg), ciprofloxacin
(5 µg), and norfloxacin (10 µg). The susceptibility disks were purchased from Biolab Inc.
(Budapest, Hungary). The plates were incubated for 16 to 18 h at 35 ◦C, and inhibition
zones were determined visually.
4.4. Bacterial DNA Purification
The bacterial DNA was extracted by the QIAamp® DNA Blood Mini Kit (QIAGEN
Inc, Chatsworth, CA, USA) following the manufacturer’s instructions. One milliliter of log-
phase culture suspension, at a concentration of 107 CFU/mL, was used for the preparation.
To trigger lysis of the bacterial cell wall, a preincubation step with 20 mg/mL lysozyme
(in 20 mM Tris HCl, pH 8.0, 2 mM EDTA, 1.2% Triton X-100) was applied. The spin
protocol was followed after incubation at 30 ◦C for 30 min. The final concentration of DNA
was quantified using NanoDrop™ Lite spectrophotometer (Thermo Fisher Scientific™,
Waltham, MA, USA) equipment. DNA samples were stored at −20 ◦C until further use.
4.5. Gene Targets
Three groups of antibiotic resistance genes were investigated in the genetic analy-
sis. ESBL genes were BlaTEM, BlaSHV, BlaOXA, and BlaCTX; plasmid-mediated quinolone
resistance genes were qnrA, qnrD, qnrB, qnrS, oqxAB, aac(6′)-Ib-cr, qepA, and qnrC. Finally,
sulfonamide genes were sul1, sul2, and sul3.
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4.6. Primers
Primer sets previously published in the literature were used with slight modifica-
tion [22–25]. The written melting temperature (Tm) of the primers was 60 ◦C in all cases.
However, although rare, some of the primers had higher calculated melting temperatures
than published. These were modified by leaving some bases on the 5′ end of the original
sequences. Thus, the specificity was unchanged but the differences in Tm were less than
1 ◦C. Primer sequences resulting amplicon lengths and references are listed in Tables 4–6.
The published primer sequences are listed, and the modifications are underlined.
Table 4. ESBL resistance genes and primers.















Table 5. Plasmid-mediated quinolone resistance genes and primers [24].
Gene Primer Sequence (5′-3′) Amplicon Size (bp)
qnrA F CAGCAAGAGGATTTCTCACG 630R AATCCGGCAGCACTATTACTC





qnrS F GCAAGTTCATTGAACAGGGT 428R TCTAAACCGTCGAGTTCGGCG




qepA F GCAGGTCCAGCAGCGGGTAG 218R CTTCCTGCCCGAGTATCGTG
qnrC F GCAGAATTCAGGGGTGTGAT 118R AACTGCTCCAAAAGCTGCTC
Table 6. Sulfonamide resistance genes and primers [26].











The same conditions and equipment were used in each PCR assay. A BIO-RAD CFX
96 instrument (Bio-Rad, Hercules, CA, USA) was used for PCR reaction. Each reaction
was performed in 10 µL containing 5 µL MMX (Fermentas Probe/ROX qPCR MasterMix,
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Fermentas, Lithuania), 1 µL template DNA, 0.5 µM forward and reverse primers. The PCR
cycling parameters were 1 cycle at 95 ◦C for 3 min, 40 cycles denaturation 95 ◦C for 15 s,
annealing at 60 ◦C for 20 s and elongation at 72 ◦C for 1 min. The PCR fragments were
separated by electrophoresis on 1.5% agarose gels containing GelRed Nucleic Acid Stain
(10,000× in water; Biotium Inc., Hayward, CA, USA) and visualized by UV illumination
(Bio-Rad Molecular Imager® GelDoc™ XR+ system with ImageLab™ Software, Bio-Rad
Laboratories, Inc., Hercules, CA, USA). Data were evaluated and compared with DNA
ladder 100–1000 bp (Bioline, London, UK) DNA marker.
4.8. Bacterial RNA Purification
E. coli 33504 and E. coli 32313 strains were cultured overnight in LB broths of pH 5 to pH
8 at 37 ◦C with shaking (OD600:0.6). Bacterial suspensions were prepared with and without
GEN ( 12 MIC) in LB medium at pH 5 to pH 8 and incubated at 37
◦C with shaking. The total
RNA was isolated after 8 h of culturing. RNA preparation was carried out in an RNase-free
environment using NucleoSpin RNA kit (Macherey Nagel, Germany) according to the
manufacturer’s instructions. Purified RNA was stored in RNase-free water in nuclease-
free collection tubes and was maintained at −20 ◦C until quantification was performed.
The concentration of the extracted RNA templates was assessed by spectrophotometry at
260 nm (Bio-Rad, Hercules, CA, USA, SmartSpec™ Plus).
4.9. Relative Gene Expression Analyses by Real-Time Reverse Transcriptase Quantitative
Polymerase Chain Reaction (RT-qPCR)
The relative gene expression levels were determined at pH 5 to pH 8 in the presence
and absence of GEN. Both E. coli strains were cultured in LB at pH 5 to pH 8 and total
RNA was isolated after 8 h of culturing. The relative expression levels of the marR mul-
tiple antibiotic resistance regulator and the sdiA quorum sensing activator genes were
determined by RT-qPCR. This involved the CFX96 Touch real-time PCR detection system
(BioRad, Hercules, CA, USA), strictly following the manufacturer’s recommendations for
the SensiFASTTM SYBR No-ROX One-Step Kit (Bioline GmbH, Luckenwalde, Germany).
Briefly, each well of the 96-well microtiter plate contained 20 µL as follows: 10 µL of the 2×
SensiFASTTM SYBR No-ROX One-Step Mix, 0.2 µL Reverse Transcriptase, 0.4 µL RiboSafe
RNase Inhibitor, 5.4 µL Diethylpyrocarbonate (DEPC)-treated water, 500 nM of each primer
and approximately 20 ng of total RNA in RNase-free water. Thermal cycling was initiated
with a denaturation step of 5 min at 95 ◦C, followed by 40 cycles each of 10 s at 95 ◦C, 30 s
at 57 ◦C, and 20 s at 72 ◦C. The relative quantities of the mRNA of each gene of interest
were determined by ∆∆CT method. Gene transcript levels were normalized against the E.
coli housekeeping gene GAPDH measured in the same sample. The primers used in the
assay shown in Table 7.
Table 7. Forward and reverse primers used for the assessment of the activity of the multiple antibiotic
resistance regulator gene marR and the quorum-sensing regulator sdiA of Escherichia coli 33504 and
32313.







GAPDH F ACTTACGAGCAGATCAAAGC 170 [26]
5. Conclusions
It is important to note that the colonization of bacteria depends on the characteristics
of the population and density related virulence factors. It can be concluded that the pH
can influence the activity of antibiotics and the function of efflux pump-related virulence
Antibiotics 2021, 10, 1431 9 of 10
factors such as quorum sensing and biofilm formation. Furthermore, the constituents and
the pH of the urine can have an impact on bacterial growth. The manipulation of pH may
increase the efficacy of antibiotics, especially in case of UTIs caused by multidrug resistant
bacteria.
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